Skip to main content
OpenTrials
Completed

NCT Number: NCT02931734

Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment

The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity by the agents Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypersensitivity Dentin Dentin Hypersensitivity Dentin Sensitivity Dentine Hypersensitivity Stomatognathic Diseases Tooth Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Federal University of Uberlandia

Uberlândia, Minas Gerais, 38400-000, Brazil

About this study

Cervical dentin hypersensitivity is a painful condition and is a clinical challenge due to different treatment strategies available. The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity. A hundred forty teeth of healthy patients of both sexes were selected. Visual Analog Scale was used pain (VAS) to measure the intensity of the patient's pain. The teeth will be randomly divided into 7 different groups according to the desensitization treatment under study: Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • presence of dentin exposure lesions with clinical diagnosis of moderate or severe tooth sensitivity
  • good oral hygiene.

Exclusion criteria

  • cavities,
  • presence of periodontal disease and or parafunctional habits,
  • cracks or enamel fractures,
  • extensive or unsatisfactory restorations,
  • recent restorations involving the labial surface,
  • dentures,
  • orthodontics.

Treatment and study plan

Resin modified glass ionomer

Drug

Prophylaxis, washing and removing water excess , apply the Clinpro forming a uniform layer of 0.5mm, lightcure for 20 seconds

Other names: Clinpro

Potassium Nitrate 2%

Drug

Prophylaxis, apply uniformly on the teeth, wait 10 minutes, remove the gel from the teeth with cotton and abundant water.

Other names: Desensibilize KF

low level laser therapy

Procedure

Prophylaxis, applying infrared laser at low power in points: mesial, buccal, distal and in the apical point in the foyer of fornix with power of 110MW for 11 seconds at each point.

Other names: Photon Lase III

Primary outcomes

  1. Level of cervical dentin hypersensitivity, measured by visual analog scale

    Time frame: 24 weeks

    Evaluate the reduction in Cervical Dentin Hypersensitivity with a 24 weeks follow up.

Sponsors and collaborators

Lead sponsor

Federal University of Uberlandia

Other

Registry information

Official study title

Analysis of the Association of Products for the Treatment of Cervical Dentin Hypersensitivity

Acronym: CDH

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Oct 13, 2016
Registry last updated
Oct 14, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.